TITLE

Polymorphisms in XPC provide prognostic information in acute myeloid leukemia

AUTHOR(S)
Xu, Peipei; Chen, Baoan; Feng, Jifeng; Cheng, Lu; Xia, Guohua; Li, Yufeng; Qian, Jun; Ding, Jiahua; Lu, Zuhong
PUB. DATE
October 2012
SOURCE
International Journal of Hematology;Oct2012, Vol. 96 Issue 4, p450
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
82535773

 

Related Articles

  • Acute Leukemia.  // Current Medical Literature: Leukemia & Lymphoma;2011, Vol. 19 Issue 1, p17 

    The article discusses several studies on acute leukemia. One study examined the frequencies of isocitrate dehydrogenase 1 (IDH1) and IDH2 mutations in cohorts of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML) and Janus kinase 3 mutation-positive...

  • Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia. Renneville, A; Boissel, N; Helevaut, N; Nibourel, O; Terré, C; Pautas, C; Gardin, C; Thomas, X; Turlure, P; Reman, O; Berthon, C; Dombret, H; Castaigne, S; Preudhomme, C // Leukemia (08876924);Dec2011, Vol. 25 Issue 12, p1918 

    A letter to the editor is presented which discusses the associated feature, prognostic significance, and prevalence of Wilms' tumor 1 (WT1) single-nucleotide polymorphism (SNP) rs16754 in the adult patients of acute myeloid leukemia (AML).

  • Acute myeloid leukaemia in old age: Can the prognosis be improved?  // Age & Ageing;Mar1998, Vol. 27 Issue 2, p91 

    Provides information on the improvements needed for the prognosis for acute myeloid leukaemia in old age. Details on a study conducted on the characteristics of acute myeloid leukaemia; Results of the study conducted on the prevalence of myeloid leukemia in old age.

  • CITATIONS AND CLINICIANS' NOTES: ACUTE LEUKEMIA.  // Current Medical Literature: Leukemia & Lymphoma;2005, Vol. 13 Issue 2, p32 

    Provides information on several studies on acute leukemia, published in various medical journals. Biological characteristics of acute leukemia; Overall cure rates of acute myeloid leukemia most contemporary treatment protocols; Focus of modern treatment programs as the cure rate for childhood...

  • Acute Leukemia. Fox, Christopher; Mead, Adam; Sellar, Rob // Current Medical Literature: Leukemia & Lymphoma;2012, Vol. 20 Issue 2, p51 

    The article presents information on medical studies on acute leukemia published in medical journals as of 2012. L. Ding et al discussed clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. S. Kayser et al looked at the prognostic impact and outcome of...

  • Chromosomal rearrangements in acute myeloid leukemia (AML). Belloni, E.; Trubia, M.; Gasparini, P.; Micucci, C.; Tapinassi, C.; Confalonieri, S.; Nuciforo, P.; Martino, B.; Lo-Coco, F.; Di Fiore, P. P.; Pelicci, P. G. // Ecancermedicalscience;2010, Vol. 4, p1 

    The article offers information on chromosome rearrangements in acute myeloid leukemia (AML).

  • AML: Biology.  // Hematology Journal;2004 Supplement 2, Vol. 5, pS148 

    Presents abstracts of studies on acute myeloid leukemia, focusing on biological aspects. CEBPA mutations, FLT3 ITD and BAALC expression define distinct prognostic subsets in normal karyotype acute myeloid leukemia; Complete mutational analysis of the commonly deleted region underlying DEL(9Q)...

  • Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease - a study within the Europe Against Cancer Program. van der Velden, V. H. J; Boeckx, N.; Gonzalez, M.; Malec, M.; Barbany, G.; Lion, T.; Gottardi, E.; Pallisgaard, N.; Beillard, E.; Hop, W. C. J.; Hoogeveen, P. G.; Gabert, J.; van Dongen, J. J. M // Leukemia (08876924);Apr2004, Vol. 18 Issue 4, p884 

    During the last decade, several studies have shown that quantification of minimal residual disease (MRD) provides prognostic information that can be used for treatment decisions in individual patients. In acute lymphoblastic leukemia, MRD information obtained at early time points during therapy...

  • Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia. Zangrando, A.; Luchini, A.; Buldini, B.; Rondelli, R.; Pession, A.; Bicciato, S.; te Kronnie, G.; Basso, G. // Leukemia (08876924);May2006, Vol. 20 Issue 5, p888 

    A letter to the editor is presented which discusses a study on the use of immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia.

  • JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers. Vicente, C.; Vázquez, I.; Marcotegui, N.; Conchillo, A.; Carranza, C.; Rivell, G.; Bandrés, E.; Cristobal, I.; Lahortiga, I.; Calasanz, M. J.; Odero, M. D. // Leukemia (08876924);Dec2007, Vol. 21 Issue 12, p2576 

    A correction to the article "JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers" is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics